Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabbiano

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|April 29, 2010
Differential expression of specific microRNA and their targets in acute myeloid leukemiaGiuseppe Cammarata, Luigi Augugliaro, Domenico Salemi, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
British Journal of Haematology|October 28, 2008
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Paola Fazi, et al.
Leukemia & Lymphoma|July 13, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Monica Fumagalli, Sabina Chiaretti, et al.
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
Blood|January 25, 2002
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized studyLuciana Annino, Maria Luce Vegna, Andrea Camera, et al.
The New England Journal of Medicine|September 9, 2005
Levofloxacin to prevent bacterial infection in patients with cancer and neutropeniaGiampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti, et al.
Blood|September 24, 2005
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolAntonella Vitale, Anna Guarini, Cristina Ariola, et al.
The Journal of Molecular Diagnostics : JMD|June 16, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic LeukemiaIrene Della Starza, Lucia A De Novi, Alessandra Santoro, et al.
Haematologica|February 4, 2021
A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocolSabina Chiaretti, Michela Ansuinelli, Antonella Vitale, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|April 29, 2010
Differential expression of specific microRNA and their targets in acute myeloid leukemiaGiuseppe Cammarata, Luigi Augugliaro, Domenico Salemi, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
British Journal of Haematology|October 28, 2008
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Paola Fazi, et al.
Leukemia & Lymphoma|July 13, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Monica Fumagalli, Sabina Chiaretti, et al.
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
Blood|January 25, 2002
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized studyLuciana Annino, Maria Luce Vegna, Andrea Camera, et al.
The New England Journal of Medicine|September 9, 2005
Levofloxacin to prevent bacterial infection in patients with cancer and neutropeniaGiampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti, et al.
Blood|September 24, 2005
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolAntonella Vitale, Anna Guarini, Cristina Ariola, et al.
The Journal of Molecular Diagnostics : JMD|June 16, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic LeukemiaIrene Della Starza, Lucia A De Novi, Alessandra Santoro, et al.
Haematologica|February 4, 2021
A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocolSabina Chiaretti, Michela Ansuinelli, Antonella Vitale, et al.
Pageof 5